DTYMK and hepatocellular carcinoma: Zhou et al. (2021) reported that high expression of DTYMK significantly corresponded to the poor OS, DSS, and relapse-free survival (RFS) in hepatocellular carcinoma. Guo et al. (2021) suggested that increased DTYMK was correlated with poor OS and DFS in hepatocellular carcinoma.